Our research projects
Find out more about the research projects you're helping us to fund. Together we can beat blood cancer.
Understanding the role of genes in how ALL develops in children
Dr Russell and her team are researching to understand more about the role genes play in how ALL develops so they can find drugs that could specifically target ALL cancer cells.
Understanding the role of the bone marrow environment in Myelodysplastic syndromes (MDS)
Dr Mian is researching a group of blood cancer called Myelodysplastic syndromes (MDS) to understand how the cells surrounding cancer cells in the bone marrow help the disease to develop and grow so he can find new ways to treat it.
Understanding why some people develop myeloma
Dr Goudswaard is studying proteins in the blood and lifestyle factors to understand why some individuals with MGUS go on to develop myeloma and others in the hope to help identify who might be more at risk.
Mapping the bone marrow to detect blood cancer early
Dr Cooper is using cutting-edge technology understand why some people with Clonal haematopoiesis of indeterminate potential (CHIP) go on to develop blood cancer.
Preventing and treating infections in patients with blood cancer following CAR-T cell therapy
Read more how Dr Hamilton and his team are researching better ways to prevent, detect, and treat infections in people with blood cancer that is more tailored to each person’s needs.
Targeting a protein to treat acute myeloid leukaemia (AML) in children
Dr Keeshan is researching to see if removing or blocking a specific protein can help make it easier to treat children with acute myeloid leukaemia (AML).
A new approach to a treating fatigue in people with chronic lymphocytic leukaemia (CLL)
Dr Bartlett and his team at the University of Surrey are testing whether a personalised, home-based program focusing on exercise and diet can reduce fatigue and improve quality of life.
Advancing CAR-T cell therapy to transform treatment and provide hope for people with myeloma
Dr Charlotte Graham's clinical trial is testing a new type of CAR-T cell therapy to find a new way to treat myeloma.
A new combination of drugs to treat Primary Central Nervous System Lymphoma (PCNSL)
Professor Fox and team are testing a new drug combination that aims to better target and treat cancer cells.
A new treatment for myeloma
Dr Alanna Green is testing a new drug that could offer a more effective way to treat myeloma and improve patient outcomes.
A new way of diagnosing and monitoring myeloma
Non-measurable myeloma (NMM) is a type of myeloma that can be hard to detect via a blood test. Dr Chan and her team are developing a new technique to diagnose and monitor people with this type of myeloma.
A new way of treating acute myeloid leukaemia (AML) in older people by reducing inflammation
Dr Valletta is studying why older people face worse outcomes in acute myeloid leukaemia (AML) and whether combining anti‑inflammatory drugs with standard AML treatments can boost effectiveness.
A new approach to treating chronic myeloid leukaemia (CML)
A new research project is exploring combined drug and nutrient‑restriction treatments to better target chronic myeloid leukaemia (CML) and improve future therapies.
Studying immune cells to help develop new treatments for babies with leukaemia
Dr Mariani and her team are researching the role of leukaemia-associated macrophages to help develop new ways to treat leukaemia in babies.
Understanding how acute myeloid leukaemia (AML) can go undetected by the immune system
Dr Lappin wants to understand how cancer cells can avoid detection by the immune system so she can find ways to help it to better target the cancer cells.
Understanding how leukaemia stem cells may help develop new treatments for AML
Dr Nisha Narayan is exploring a new technique using leukaemia stem cells to predict how people with AML might respond to existing treatments.
Using special cells in the bone marrow to help improve treatment of AML
Read more about how Dr Tissot and her team plan to study special cells in the bone marrow to help predict treatment outcomes and develop better treatments for people with AML.
Understanding why people with acute myeloid leukaemia (AML) don’t always respond to treatment
Many people with acute myeloid leukaemia (AML) see their cancer come back. Dr Singh is studying a group of proteins to understand more about why drugs stop working.
Using the immune system to develop a new treatment for non-Hodgkin lymphoma (NHL)
Dr Blunt and team are looking for new ways to treat people with NHL using immunotherapy that activates the immune system to attack lymphoma cells.
Understanding how B-cell acute lymphoblastic leukaemia (B-ALL) spreads to the brain
B-cell acute lymphoblastic leukaemia (B-ALL) can spread to the brain and spinal cord, making it harder to treat in children. Dr Duguid will study brain tissue to find better treatments.
Targeting transcription factors in blood cancer
Read more about how Dr Feldhahn plans to develop new scientific technology which he hopes could lead to a new drug treatment for acute lymphoblastic leukaemia (ALL).
Keep in touch with us
Get the latest news from Blood Cancer UK directly to your inbox
We will keep you updated about our work and the ways you can help, including campaigns and events. We promise to respect your privacy and we will never sell or swap your details.